CAlcified Coronary Lesions Identification & Quantification With X Rays
NCT: NCT07417150 · COMPLETED
Brief Summary
The CALIQX trial is a prospective, multicenter, non-randomized pilot study comparing the 3DStent and IVUS methods for quantifying native coronary calcifications. The trial falls under classification 4.3 according to the classification and evaluation process under EU Regulation 2017/745 (MDR) and national adaptation of clinical investigations concerning medical devices: CE-marked medical device (any class), used off-label without the objective of CE marking or establishing conformity. Compare the evaluation of native coronary calcifications with 3D Stent tool versus evaluation by intracoronary IVUS imaging.
Frequently Asked Questions
What is CAlcified Coronary Lesions Identification & Quantification With X Rays?
CAlcified Coronary Lesions Identification & Quantification With X Rays is a clinical trial registered under NCT07417150. Current status: COMPLETED.
What is the status of NCT07417150?
The current status of NCT07417150 (CAlcified Coronary Lesions Identification & Quantification With X Rays) is: COMPLETED.
When did CAlcified Coronary Lesions Identification & Quantification With X Rays start?
CAlcified Coronary Lesions Identification & Quantification With X Rays started on 2025-11-14.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.